PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New brochure from Copley Scientific delivers essential information on its upgraded pharmaceutical testing range

02 February 2016: Nottingham, UK:The latest version of ‘Quality Solutions for the Testing of Pharmaceuticals’ from Copley Scientific provides detailed information for those seeking assistance with the interpretation and application of regulatory guidance, as well as highlighting new additions to the company’s extensive range. Considered a ‘go to’ resource for expert advice that is rooted in current regulatory guidance and pharmacopoeial chapters, the brand new brochure can be freely downloaded from the Copley website – www.copleyscientific.com, with printed versions available on request fromsales@copleyscientific.co.uk.
The 2016 brochure covers the latest international requirements for testing the safety, quality and efficacy of  transdermals, powders and granules, tablets and capsules, suppositories, creams and ointments, presenting the Copley range equipment within the context of how it can be used to efficiently gather essential data to meet research, development and QC needs. The latest edition has been comprehensively revised; most notably to reflect an increased focus on semisolids testing equipment for creams, ointments and gels for topical use.
Among the new tools making their debut in the 2016 brochure are two Vertical Diffusion Cells (VDCs) for the accurate and reproducible in vitro drug release testing of topical semisolid dosage forms, in accordance with the recently updated USP chapter <1724>. These are complemented by the Vertical Diffusion Cell Test System Model HDT 1000; a compact unit which comprises of 10 test stations and enables the precise control of test conditions. The refreshed offering for semisolids is completed by the new Vacuum Deaeration Apparatus, which provides de-gassed media, maintained at the required temperature, to improve the accuracy of drug release measurements.
Mark Copley, Sales Director of Copley Scientific, comments, “The brochure is an important element of the support that we provide to our customers as they strive to develop new pharmaceutical products and ensure ongoing manufacturing consistency, efficacy and safety. Our latest version exemplifies this approach, combining up to date regulatory guidance and essential industry information with the latest product innovations to meet our customers’ needs. Here at Copley, we place strong emphasis on developing high quality, durable equipment, manufactured in the UK and supported with education and training that help to maximise value. As pharmaceutical testing requirements continue to evolve, feedback suggests that both new and experienced scientists in the field find our brochure a useful and valuable source of information.”
To find out more about these products and the rest of Copley Scientific range, download the brochure at www.copleyscientific.com

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026